Addiction

Article	Citations
Issue Information	209
Commentary on Borodovsky et al.: Enhancing research on THC quantification—Consumer awareness through accurate labelling	180
An Addiction series on regional perspectives on addiction‐related problems	179
Society for the Study of Addiction Annual Conference 2024	122
	94
	92
Education matters: longitudinal pathways to mid‐life heavy drinking in a national cohort of black Americans	88
Impulsivity behaviors and white matter mediate the relationship between genetic risk for cannabis use disorder and early cannabis use in adolescents	86
Will Australia's tightened prescription system reduce nicotine vaping among young people?	86
Commentary on Nower et al: The Pathways Model should apply to non‐clinical gambling patterns	80
Significant changes in preference of illicit drug use in a population of Hanoi, Vietnam—A 6‐year wastewater study (2018–2023)	80
Commentary on Keyes and Patrick: Changes in psychedelic use in the United States may require changes in our narrative of psychedelic harms	80
National profile on substance use, substance use‐related problems and policy: The case of Chile	74
Structure and stability of internet gaming disorder from childhood to late adolescence: A 5‐wave birth cohort study	70
	68
Estimating recent trends in alcohol sales in the United Kingdom from alcohol duty revenue	67
Systematic review and meta‐analyses of cytisine to support tobacco cessation	66
Does recreational cannabis legalization change cannabis use patterns? Evidence from secondary school students in Uruguay	66
Rare but relevant series	57
Cannabis: Global Histories by Lucas Richert and James H. Mills, editors	56
How substance use prevention research gets used in United States federal policy	55
Naloxone administration—no balance without titration	52
Response to Hall et al.: Prescription psychostimulants for amphetamine‐type stimulant use disorder ‐ acknowledging challenges but not giving up on its potential cost‐effectiveness	50
Commentary on Stull et al.: Considering person‐specific heterogeneity when modeling time‐varying trends	49
Cost‐effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO‐HCV trial	47

Quantifying alcohol‐attributable disability‐adjusted life years to others than the drinker in Aotearoa/New Zealand: A modelling study based on administrative data	47
Did the under‐reporting of meth/amphetamine use increase in a general population survey in Australia as negative media coverage increased?	45
Assessing the impacts of alcohol outlets on crime as a natural experiment: agglomeration, churning and spatial effects	44
Nicotine strength of e‐liquids used by adult vapers in Great Britain: A population survey 2016 to 2024	42
Predictors of substance use during treatment for addiction: A network analysis of ecological momentary assessment data	42
Association of topiramate prescribed for any indication with reduced alcohol consumption in electronic health record data	40
Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial	37
Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications	35
Risk of readmission among individuals with cannabis use disorder during a 15‐year cohort study: the impact of socio‐economic factors and psychiatric comorbidity	35
Age, period and cohort effects of heavy episodic drinking by sex/gender and socioeconomic position in Canada, 2000–2021	34
Austin Bradford Hill’s ‘Environment and disease: Association or causation’	34
Commentary on Lange et al.: Acute alcohol use before suicide—is it contributing to an increase in suicide rates in the United States?	33
The use of financial incentives for smoking cessation in pregnant women: A parallel‐group randomised controlled trial protocol	32
ABC‐training as a new intervention for hazardous alcohol drinking: Two proof‐of‐principle randomized pilot studies	31
Recent decline in Chinese alcohol production and consumption: Potential contributing factors and the role of globally recommended measures	31
Non‐alcoholic beverage consumption among US adults who consume alcohol	31
Use of cessation products, e‐cigarettes and cigarette cessation outcomes among adults with substance use problems: Results from 2013–2021 (Waves 1–6) of the Population Assessment of Tobacco and Health	30
Risky alcohol consumption among women in Australia attending breast screening services: an exploratory cross‐sectional study	29
England's disposable vape ban: An inadequate solution to youth vaping with potential unintended consequences	29
Author Index	29
Commentary on Metcalfe et al.: ‘What works in AOD is when it feels like I am driving’ (Craig W, alcohol and drug peer worker)	29
New Books	29
Commentary on Lannoy et al.: The continued value of within‐family designs in addiction and psychiatric research	28
Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?	28
Longitudinal trajectories of marijuana use in tobacco products among young adult Texas college students from 2015 to 2019	28
	28
Neurophysiological error processing and addiction self‐awareness correlates of reduced insight in cannabis use disorder	28
	27
Clinical alcohol guidelines are welcome—but upstream action is paramount	27
Issue Information	27
Obstetric pain management for pregnant women with opioid use disorder: A qualitative and quantitative comparison of patient and provider perspectives (QUEST study)	26
Issue Information	26
Estimating the impact of a police education program on hepatitis C virus transmission and disease burden among people who inject drugs in Tijuana, Mexico: A dynamic modeling analysis	26
How research and policy can shape driving under the influence of cannabis	26
A comparative study of treatment retention in opioid use disorder: Subcutaneous injectable versus sublingual buprenorphine	25
Commentary on Motschman et al.: Moving behavioral economic demand into the real world means moving beyond single schedules of reinforcement	25
Commentary on Luukkonen et al.: Policy possibilities for reducing public health harms related to pregnant people’s alcohol consumption	25
Pain in people seeking and receiving opioid agonist treatment: A systematic review and meta‐analysis of prevalence and correlates	25
Perspectives on addiction‐related problems in India	25
Impacts of recreational cannabis legalization on cannabis use: a longitudinal discordant twin study	24
Age‐based differences in quantity and frequency of consumption when screening for harmful alcohol use	24
Cannabis research in context: The case for measuring and embracing regional similarities and differences	24
Commentary on Amin‐Esmaeili et al .: Non‐abstinence outcomes in stimulant clinical trials—Why deny improvement?	24
A return on investment analysis for the 2017 increase in alcohol excise taxation in Lithuania	24
Age–period–cohort analysis of past 12‐month cannabis use in Germany (1995–2021)	24
Implications of the shift to DSM‐5 for alcohol use disorder prevalence estimates in the National Survey on Drug Use and Health	24
Changes in wastewater measures of alcohol consumption in Alice Springs, Australia, 1 year after the introduction of restrictions on alcohol sales	23
Genetic support of a causal relationship between cannabis use and educational attainment: a two‐sample Mendelian randomization study of European ancestry	23
Evaluating the causal effect of tobacco smoking on white matter brain aging: a two‐sample Mendelian randomization analysis in UK Biobank	23
Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: Challenges and opportunities	23

Identifying and describing trajectories of alcohol use frequency and binge drinking frequency among those aged 15–30 years in a national cohort of US adolescents: A group‐based trajectory modeling app	23
The association between family environment and food addiction in children and adolescents: A prospective cohort study	23
	23
Drug Overdoses During the COVID‐19 Pandemic Among Recently Homeless Individuals	23
Effect of vaping on past‐year smoking cessation success of Australians in 2019—evidence from a national survey	22
Deficits in general and smoking‐specific response inhibition in the Go/No‐Go task in individuals who smoke: A cross‐sectional analysis	22
Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review	22
Systematic review of symptom‐level networks of alcohol use disorder	22
Issue Information	22
New Books	22
Issue Information	21
‘It's not what you'd term normal smoking’: a qualitative exploration of language used to describe heated tobacco product use and associated user identity	21
	21
Issue Information	21
Issue Information	21
Response to Luz & Mash on cardiac toxicity of ibogaine	21
	20
Disentangling the contributions of alcohol use disorder and alcohol‐related liver disease towards dementia: A population‐based cohort study	20
Prosecuting Poverty, Criminalizing Care. By WendyBach, Cambridge, UK: Cambridge University Press. 2022. ISBN: 9781108465533	20
Commentary on Schmidt et al.: Informed patient preference and prioritizing access to medications for opioid use disorder for pregnant individuals	20
Commentary on Petrilliet al.: Assessing cannabis use in real‐world settings ‐ advances using standard THC units	20
Commentary on Brothers et al.: The role of safer environment interventions in addressing injecting‐related bacterial and fungal infections	20
Social genetic effects for drug use disorder among spouses	20
Fatal drug overdoses in healthcare workers: A thematic framework analysis of coroner reports	20
New perspectives on how to formulate alcohol drinking guidelines: Response to commentaries	20
Drugs, Identity and Stigma. By MichelleAddison, WilliamMcGovern & RuthMcGovern. Chan, Switzerland: Palgrave Macmillan, 2022. ISBN: 9783030982867	20
The Opioid Epidemic in the United States: Missed Opportunities and Policy Failures. By Kant B.Patel & Mark E.Rushefsky, London, UK: Routledge, 2022. ISBN: 9781032105215	20
‘I'd rather have worse gums than worse lungs’: Young people's views of nicotine pouches in the UK	19
Evaluating the impact of vaping facts films on vaping harm perceptions among young adults in the UK: A randomized on‐line experiment	19
Changing patterns of nicotine product use and nicotine dependence among United States high‐school students: The National Youth Tobacco Survey, 2014–2023	19
The interaction of e‐cigarette use and mental health symptoms on risk of cigarette smoking initiation among young adults in the United States	19
Patient outcomes following buprenorphine treatment for opioid use disorder: A retrospective analysis of the influence of patient‐ and prescriber‐level characteristics in Massachusetts, USA	19
Cannabis vaping and mental health: The association of Δ‐9‐tetrahydrocannabinol and cannabidiol with anxiety and depressive symptoms—Findings from the United States National Youth Tobacco Survey (2021–	19
Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era	19
Nicotine pouch use by sex, school type and tobacco product use among Finnish adolescents during the 2023 change in regulatory scheme with deregulated sales	19
Non‐invasive brain stimulation for smoking cessation: a systematic review and meta‐analysis	19
Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: A systematic review and meta‐analysis	19
Response to Xiao et al.: If everything is a loot box, nothing is	18
New Books	18
Rare but relevant: Hydrocarbons and sudden sniffing syndrome	18
Daily associations between sleep and alcohol use among veterans: Acute and cumulative effects	18
Commentary on Craft et al.: Drug contaminants and substitutions in illicit vapes represent a major health risk	18
Sludge, dark patterns and dark nudges: A taxonomy of online gambling platforms' deceptive design features	18
Issue Information	18
Addiction Lives: Robin Davidson	18
Challenges and opportunities for further research involving the cannabis‐to‐opioid use transition	18
Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries	18
Addiction Lives: Sir Ian Gilmore	18
Commentary on Jones et al.: We must consider emergency medical services data an opportunity for a view into a community	18
What policies the US Food and Drug Administration should pursue in response to the addiction and overdose crisis	18
The price of a cigarette: 20 minutes of life?	17
Offering e‐cigarettes for smoking cessation and reduction in people with mental illness (ESCAPE): Protocol for a randomized controlled trial	17
Striatal dopamine D2 receptor availability as a predictor of subsequent alcohol use in social drinkers	17
Commentary on Yang et al.: The need for a renewed focus on identifying and responding to chronic pain among people with substance use disorders	17
How people decide to consume (more) alcohol when feeling stressed	17
Should contingency management protocols and dissemination practices be modified to accommodate rising stimulant use and harm reduction frameworks?	17
Motivational smoking cessation counselling and community‐based follow‐up after hospitalisation for vascular disease: A randomised controlled trial	17
Multivariable machine learning prediction of risky alcohol use in contemporary youth	17
Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type	17
Do internalising or externalising behaviours in adolescence mediate the child maltreatment‐alcohol substance use relationship?	17
Alcohol drinking, DNA methylation and psychiatric disorders: A multi‐omics Mendelian randomization study to investigate causal pathways	17
Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID‐19 pandemic: An interrupted time‐series analysis in	16
Systematic review and meta‐analysis investigating nicotine, cotinine and carbon monoxide exposures in people who both smoke and use nicotine replacement therapy	16
Rapid growth in disposable e‐cigarette vaping among young adults in Great Britain from 2021 to 2022: a repeat cross‐sectional survey	16
Commentary on Sun and Tang: Measurement assessment and validity in problematic smartphone use	16
Issue Information	16
Effect of a workplace mobile phone‐based instant messaging intervention on smoking cessation: a cluster‐randomized controlled trial	16
The advantages and downsides of online focus groups for conducting research on addictive online behaviours	16
New Books	16
Evaluating the impact of minimum unit pricing for alcohol on road traffic accidents in Scotland after 20 months: An interrupted time series study	16
How to interpret studies on the impact of legalizing cannabis	16
Differences in benefits of office based opioid treatment: Secondary analyses across sub‐groups in the PROUD randomized controlled implementation trial	16
Disparities in the receipt of alcohol brief intervention: The intersectionality of sex, age, and race/ethnicity	16
	16
Yes, nitrous oxide addiction undeniably exists!	16
Issue Information	15
The geography of sobriety checkpoints and alcohol‐impaired driving	15
Commentary on Jackson et al.: The role of regional tobacco control in centralised nations	15
Zero tolerance for 0%? How should clinicians and other practitioners respond to the use of alcohol‐free and low‐alcohol products in higher risk groups	15
Commentary on Lin et al.: The importance of valid reference standards in training supervised machine learning classifiers to detect alcohol misuse	15

Issue Information	15
Association between change in alcohol use reported during routine healthcare screening and change in subsequent hospitalization: A retrospective cohort study	15
Stakeholders cannot simply wait for the gambling evidence‐base to develop: We must all help to build it	15
	15
Mainstreaming smoking cessation brief advice in health systems using the United Nations human rights system	15
Prescribing of extended release buprenorphine injection for Medicaid beneficiaries, 2018–2022	15
The efficacy of an internet‐based cognitive behavioral program added to treatment‐as‐usual for alcohol‐dependent patients in primary care: a randomized controlled trial	15
Referees	14
Issue Information	14
Cannabis use and sleep problems among young adults by mental health status: A prospective cohort study	14
Harmful compared to what? The problem of gaming and ambiguous causal questions	14
Issue Information	14
Cost–utility analysis of provision of e‐cigarette starter kits for smoking cessation in emergency departments: An economic evaluation of a randomized controlled trial	14
Issue Information	14
Using ecological momentary assessment to quantify Δ‐9‐tetrahydrocannabinol and cannabidiol use across different forms of cannabis: Feasibility in a sample of Canadian young adults reporting frequent c	14
Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug‐testing and law enforcement	14
Clinical characteristics of heroin overdose deaths among older adults in Australia, 2000–2025	14
Addressing the overdose crisis in North America with bold action	14
Cannabis use disorder and adverse cardiovascular outcomes: A population‐based retrospective cohort analysis of adults from Alberta, Canada	14
The association between state cannabis policies and cannabis use among adults and youth, United States, 2002–2019	14
Addiction Lives: Viv Evans	14
Better data access can lead to better collaborative conclusions: Results of a discussion with Heirene	14
Functional connectivity in the central executive network predicts changes in binge drinking behavior during emerging adulthood: an observational prospective study	14
Validating transdermal alcohol biosensors: a meta‐analysis of associations between blood/breath‐based measures and transdermal alcohol sensor output	14
Effects of interventions to combat tobacco addiction: Cochrane update of 2021 to 2023 reviews	14
Is methamphetamine blood concentration in emergency department patients associated with the clinical picture?	13
	13
On the duration of cannabis effects and the presence of THC in the body	13
Quantification of racial and ethnic disparities in alcohol‐related problems in light of different methodological approaches	13
Population‐level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost‐effectiveness an	13
Within‐week associations between alcohol and other substance use and interaction with naltrexone among sexual and gender minority men in San Francisco, California, USA	13
Effect of 3 months and 12 months of financial incentives on 12‐month postpartum smoking cessation maintenance: A randomized controlled trial	13
Changes to our Editorial Team	13
Drunken snakes and sober owls: ancient authors on the relationship between animals and wine	13
Within‐person associations of escalated electronic nicotine delivery systems use with cigarette, alcohol, marijuana and drug use behaviors among US young adults	13
Predicting severe alcohol use disorders in primary care using number of heavy drinking days	13
The impacts of COVID‐19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia	13
Standardised packs and larger health warnings: visual attention and perceptions among Colombian smokers and non‐smokers	13
Issue Information	13
Changing trends in drug overdose mortality in Spain, 2001–2022	13
Commentary on Hyland et al.: Digital treatment for alcohol use disorders ‐ challenges and opportunities	13
Effect of perioperative high‐dose transdermal nicotine patch on pain sensitivity among male abstinent tobacco smokers undergoing abdominal surgery: A randomized controlled pilot study	13
Understanding perceived addiction to and addictiveness of electronic cigarettes among electronic cigarette users: a cross‐sectional analysis of the International Tobacco Control Smoking and Vaping (IT	13
Amphetamine use and mental health difficulties across adolescence and young adulthood: An integrative data analysis of four Australasian cohort studies	13
Evaluation of the effectiveness of cytisine for the treatment of smoking cessation: A systematic review and meta‐analysis	13
A systematic review and meta‐analysis of factors associated with adolescent substance use in Africa, 2000 to 2020	12
Clinical management of psychostimulant withdrawal: review of the evidence	12
Comparison of strength and adulteration between illicit drugs obtained from cryptomarkets versus off‐line	12
Efficacy of cannabidiol alone or in combination with Δ‐9‐tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence	12
Classifying national drinking patterns in Europe between 2000 and 2019: A clustering approach using comparable exposure data	12
Understanding successful policy innovation: The case of Portuguese drug policy	12
How effective are remote and/or digital interventions as part of alcohol and drug treatment and recovery support? A systematic review and meta‐analysis	12
Evaluation of statewide restrictions on e‐cigarette nicotine strength—United States, 2017–2022	12
Cannabis policy bundles and traffic fatalities in the American States over time	12
Prolonged diacetylmorphine take‐home during the COVID‐19 pandemic—Results of a retrospective cohort study	12
Evaluating the effectiveness of e‐cigarettes compared with usual care for smoking cessation when offered to smokers at homeless centres: protocol for a multi‐centre cluster‐randomized controlled trial	12
Development and evaluation of a risk algorithm predicting alcohol dependence after early onset of regular alcohol use	12
The impact of road safety policies in a deregulated alcohol tax environment in Hong Kong: a 15‐year time series analysis	12
Alcohol use disorder criteria exhibit different comorbidity patterns	12
Decentering alcohol: Non‐drug pleasure and reinforcement as an alternative target	12
Mortality in the SuperMIX cohort of people who inject drugs in Melbourne, Australia: a prospective observational study	12
Packaging of disposable vaping products and e‐liquids in England, Canada and the United States: A content analysis	12
Health impacts of a scale‐up of supervised injection services in a Canadian setting: an interrupted time series analysis	12
Deaths of despair	12
Commentary on Manthey et al .: No more missed opportunities—We need to address the absence of robust and comprehensive evaluations about the real‐world i	12
How much does the absence of the ‘hidden population’ from United Kingdom household surveys underestimate smoking prevalence?	12
Why it is important to conduct gambling research that is fair and free from conflicts of interest	11
Nitrous oxide: The label ‘potentially addictive’ may do more harm than good	11
Changes to our editorial team	11
Prenatal smoking, alcohol and caffeine exposure and offspring externalizing disorders: a systematic review and meta‐analysis	11
Non‐alcoholic beer labeling in the United States	11
Cannabis and sport: A World Anti‐Doping perspective	11
Post‐legalization shifts in cannabis use among young adults in Georgia—A nationally representative study	11
Will Australia's tightened prescription system reduce nicotine vaping among young people?	11
When should we conduct large‐scale evaluations?	11
Future Directions for the International Cannabis Toolkit (iCannToolkit)	11
The environmental impact of tobacco products: Time to increase awareness and action	11
Drug consumption rooms are effective to reduce at‐risk practices associated with HIV/HCV infections among people who inject drugs: Results from the COSINUS cohort study	11
Let's talk about pleasure: Bridging the sociology and public health divide	11
Referees	11
E‐cigarette cessation and transitions in combusted tobacco smoking status: longitudinal findings from the US FDA PATH Study	11
Does a local Alcohol Health Champion programme have a measurable impact on health and crime outcomes? A natural experiment evaluation of Communities in Charge of Alcohol (CICA) based on triangulation	11
Commentary on Bade et al.: Threat of nitazenes and other potent synthetic opioids—Is Europe prepared? Time to respond and to learn	11
Systematic review of patient‐reported outcome measures for opioid use disorder recovery	11
Extended‐release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review	11
GLP‐1R agonist medications for addiction treatment	11
The risks of misclassifying addictive food substances as non‐addictive	11
Issue Information	11
The relationship between Problem Gambling Severity Index scores and suicidality: Results of a 9‐year cohort study of young United Kingdom adults	10
Call for papers on psychedelic‐assisted treatment for substance use disorders	10
Commentary on Allaf et al.: Comparing countries with different legal cannabis markets can inform on the impact of regulating product type and potency	10
Efficacy of cognitive behavioral therapy‐based smartphone app for smoking cessation in China: A randomized controlled trial	10
Does gambling expenditure have any effect on crime?	10
Cannabidiol does not attenuate acute delta‐9‐tetrahydrocannabinol‐induced attentional bias in healthy volunteers: A randomised, double‐blind, cross‐over study	10
Issue Information	10